| STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
JAK1 |
|
102.000 |
Evidence |
|
| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
102.000 |
Evidence |
O
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PARD6B |
PARD6B, PAR6B: Partitioning defective 6 homolog beta |
101.000 |
Evidence |
|
| NBN |
NBN, NBS, NBS1, P95: Nibrin |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
101.000 |
Evidence |
|
| HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
LILRB1 |
IPI00385703 |
101.000 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
INSR |
INSR: Insulin receptor precursor |
101.000 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
101.000 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
101.000 |
Evidence |
O
|
| INSR |
INSR: Insulin receptor precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
101.000 |
Evidence |
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD3 |
PSMD3: 26S proteasome non-ATPase regulatory subunit 3 |
100.000 |
Evidence |
O
|
| COPZ1 |
COPZ1, COPZ, CGI-120, HSPC181: Coatomer subunit zeta-1 |
COPG |
|
100.000 |
Evidence |
O
|
| PSMD12 |
PSMD12: 26S proteasome non-ATPase regulatory subunit 12 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
100.000 |
Evidence |
O
|
| COPB |
IPI00556322 |
COPG |
|
100.000 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF2B4 |
IPI00220232 |
100.000 |
Evidence |
|
| ERCC5 |
ERCC5, ERCM2, XPG, XPGC: DNA-repair protein complementing XP-G cells |
GTF2H1 |
GTF2H1, BTF2: TFIIH basal transcription factor complex p62 subunit |
100.000 |
Evidence |
O
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
100.000 |
Evidence |
O
|
| SUMO1 |
SUMO1, SMT3C, OK/SW-cl.43, SMT3H3, UBL1: Small ubiquitin-related modifier 1 prec |
SAE1 |
SAE1, AOS1, SUA1, UBLE1A: SUMO-activating enzyme subunit 1 |
99.180 |
Evidence |
|
| VTI1A |
VTI1A: Vesicle transport through interaction with t-SNAREs homolog 1A |
VPS45A |
VPS45A, VPS45, VPS45B: Vacuolar protein sorting-associated protein 45 |
99.180 |
Evidence |
O
|
| HCN1 |
HCN1, BCNG1: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
HCN2 |
HCN2, BCNG2: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gate |
98.7 |
Evidence |
O
|
| DLL1 |
DLL1, UNQ146/PRO172: Delta-like protein 1 precursor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
98.7 |
Evidence |
O
|
| GDI2 |
GDI2, RABGDIB: Rab GDP dissociation inhibitor beta |
RAB8A |
RAB8A: RAB8A protein |
98.610 |
Evidence |
O
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
98.230 |
Evidence |
|
| HDAC3 |
HDAC3: Histone deacetylase 3 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
98.170 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SYK |
SYK: Tyrosine-protein kinase SYK |
96.570 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
96.570 |
Evidence |
O
|
